✦ LIBER ✦

Repeated Daclizumab Administration to Delay the Introduction of Calcineurin Inhibitors in Heart Transplant Patients With Postoperative Renal Dysfunction

✍ Scribed by Ignacio J. Sánchez Lázaro; Luis Almenar Bonet; Luis Martínez Dolz; Francisco Buendía Fuentes; Josep Navarro Manchón; Jaime Agüero Ramón-Llin; José Luis Vicente Sánchez; Antonio Salvador Sanz

Book ID: 118499295
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 61 KB
Volume: 64
Category: Article
ISSN: 1885-5857
DOI: 10.1016/j.rec.2010.05.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term calcineurin inhibitor “holiday

Long-term calcineurin inhibitor “holiday” using daclizumab in a heart transplant patient with acute renal dysfunction

✍ B. Potter; N. Giannetti; R. Cecere; M. Cantarovich 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Introduction of MMF in conjunction with

Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction

✍ Arno Kornberg; Bernadette Küpper; Merten Hommann; Johannes Scheele 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Replacement of calcineurin inhibitors wi

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study

✍ Hans J Schlitt; Annette Barkmann; Klaus HW Böker; Nikos Emmanouilidis; Jens Rose 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 84 KB

361: The effect of sirolimus on renal fu

361: The effect of sirolimus on renal function when used in heart transplantation patients with calcineurin inhibitor related renal impairment

✍ A. Al Riyami; M. Chandavimol; C. Imai; L. Straatman; A. Kaan; A. Ignaszewski 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Improvement of renal function after the

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro

193: Calcineurin inhibitor “holiday” wit

193: Calcineurin inhibitor “holiday” with anti-CD25 monoclonal antibody coverage results in an improvement of acute renal dysfunction in heart transplant patients without increasing the risk of acute rejection

✍ M. Cantarovich; N. Giannetti; G. Fontaine; R. Chartier; E. Cyr; R. Cecere 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB